Why Are EzriCare Eye Drops Recalled?

<p><strong>The main reasons for the EzriCare Eye Drops recall are:</strong></p> <ul> <li>Possible bacterial contamination of the product.</li> <li>The presence of drug-resistant Pseudomonas Aeruginosa (CRPA) in consumers.</li> <li>The ongoing investigation by CDC into the manufacturing process.</li> </ul> <h4>Possible bacterial contamination of the product</h4> <p>EzriCare Artificial Tears and Delsam Pharma Artificial Tears are recalled due to a risk of bacterial contamination.</p> <p>This contamination could have potentially originated during the manufacturing or transportation process of these products.</p> <h4>The presence of drug-resistant Pseudomonas Aeruginosa (CRPA) in consumers</h4> <p>Consumers have been found to have bacterial infections caused by Drug-Resistant Pseudomonas Aeruginosa (CRPA).</p> <p>These infections are directly linked to the use of the recalled eye drop products.</p> <h4>The ongoing investigation by CDC into the manufacturing process</h4> <p>The <a href="https://www.nytimes.com/2023/02/02/business/eye-drops-ezricare-infections-cdc.html">Centers for Disease Control and Prevention (CDC) is currently investigating</a> both opened and unopened bottles of these eye drops.</p> <p>The aim of the investigation is to determine whether the contamination occurred during the manufacturing process.</p> <p>To conclude, EzriCare Eye Drops were recalled due to potential bacterial contamination, infections caused by CRPA in consumers, and the ongoing investigation by the CDC into the product’s manufacturing process.</p>

Which Eye Drops are Contaminated?

<p><strong>The following eye drops are contaminated and have been recalled:</strong></p> <ul> <li>EzriCare Artificial Tears Lubricant Eye Drops.</li> <li>Delsam Pharma Artificial Tears Lubricant Eye Drops.</li> <li>Delsam Pharma’s Artificial Eye Ointment.</li> <li>Brimonidine Tartrate Ophthalmic Solution, 0.15%.</li> <li>Purely Smoothing 15% MSM Drops.</li> </ul> <h4>EzriCare Artificial Tears Lubricant Eye Drops</h4> <p>This is an over-the-counter product used by a large number of consumers.</p> <p>The product has been linked to eye infections and thus, has been recalled.</p> <h4>Delsam Pharma Artificial Tears Lubricant Eye Drops</h4> <p>Similar to the EzriCare drops, Delsam Pharma’s artificial tears have also been recalled.</p> <p>This is also an over-the-counter product that is connected to reported eye infections.</p> <h4>Delsam Pharma’s Artificial Eye Ointment</h4> <p>This is another over-the-counter product from Delsam Pharma that has been linked to eye infections and consequently, has been recalled.</p> <h4>Brimonidine Tartrate Ophthalmic Solution, 0.15%</h4> <p>This prescription eye drop is used by patients diagnosed with open-angle glaucoma or ocular hypertension.</p> <p>Due to the link with eye infections, this product has also been recalled.</p> <h4>Purely Smoothing 15% MSM Drops</h4> <p>This over-the-counter product is the final eye drop on the recall list.</p> <p>It too has been linked to cases of eye infections.</p> <p>To conclude, the contaminated and recalled eye drops include products from both EzriCare and Delsam Pharma, including their Artificial Tears, the Artificial Eye Ointment from Delsam Pharma, the Brimonidine Tartrate Ophthalmic Solution, and the Purely Smoothing 15% MSM Drops.</p>

What Health Problems May Be Associated With EzriCare Contaminated Eye Drops?

<p>Let’s explore the potential health issues linked to the use of EzriCare contaminated eye drops.</p> <p><strong>Potential health problems associated with EzriCare contaminated eye drops include:</strong></p> <ul> <li>Severe eye infections</li> <li>Risk of blood infection</li> <li>Potential for permanent or partial vision loss</li> <li>Urinary tract infections</li> <li>Respiratory infections</li> </ul> <h4>Severe Eye Infections</h4> <p>Bacterial contamination is a serious concern when it comes to artificial tears eye drops, such as those manufactured by Global Pharma Healthcare.</p> <p>The type of bacterial contamination present can lead to serious eye infections, necessitating intensive medical treatment.</p> <h4>Risk of Blood Infection</h4> <p>In some severe cases, the bacteria from contaminated eye drops can potentially enter the bloodstream leading to sepsis, a serious and potentially fatal blood infection.</p> <p>This can occur if the bacteria move from the eye into the bloodstream.</p> <h4>Potential for Permanent or Partial Vision Loss</h4> <p>Infections caused by contaminated eye drops can lead to damage to the eye, which can result in permanent or partial vision loss.</p> <p>If the infection is not treated promptly and effectively, the risk for significant vision loss increases.</p> <h4>Urinary Tract Infections</h4> <p>Although less common, the bacteria from contaminated eye drops can potentially cause urinary tract infections.</p> <p>These types of infections can lead to painful urination and may require antibiotic treatment.</p> <h4>Respiratory Infections</h4> <p>Similarly, the bacteria present in the contaminated eye drops can potentially lead to respiratory infections if it finds its way into the respiratory tract.</p> <p>This could happen if the eye drops are accidentally ingested or enter the respiratory tract.</p> <p>To conclude, the potential health problems associated with the use of EzriCare contaminated eye drops include severe eye infections, blood infections, permanent or partial vision loss, urinary tract infections, and respiratory infections.</p> <p>It is critical to avoid using contaminated eye drops to prevent these health complications.</p>

Is There an EzriCare Class Action Lawsuit?

<p>The question of whether there is an EzriCare Class Action Lawsuit has been asked frequently.</p> <p><strong>Key Points:</strong></p> <ul> <li>There is currently no EzriCare Class Action Lawsuit.</li> <li>A multidistrict litigation (MDL) may be established.</li> <li>MDL and class action lawsuits are different types of litigations.</li> <li>Potential settlements in an EzriCare MDL would be distributed according to individual case facts and damages.</li> <li>In a class action lawsuit, potential settlements would be distributed evenly among all plaintiffs.</li> </ul> <h4>There is Currently No EzriCare Class Action Lawsuit:</h4> <p>As of now, there is no EzriCare Class Action Lawsuit in place.</p> <p>This is a point of interest for many individuals who have been affected by EzriCare Artificial Tears and Delsam Pharma Artificial Tears.</p> <h4>A Multidistrict Litigation (MDL) May Be Established:</h4> <p>In response to injuries and serious infections resulting from EzriCare Artificial Tears and Delsam Pharma Artificial Tears, a multidistrict litigation (MDL) may be established.</p> <p>This is a legal procedure designed to speed up the process of handling complex cases, such as those involving multiple plaintiffs spread across a wide geographic area.</p> <h4>MDL and Class Action Lawsuits Are Different Types of Litigations:</h4> <p>While they may seem similar, MDL and class action lawsuits are different types of litigations.</p> <p>Understanding this difference is crucial for those involved in such cases.</p> <h4>Potential Settlements in an EzriCare MDL Would Be Distributed According to Individual Case Facts and Damages:</h4> <p>If an EzriCare MDL is established, any potential settlement would be distributed to plaintiffs based on the facts and damages of their individual case.</p> <p>This means that each plaintiff’s compensation would reflect the specific harm they have suffered.</p> <h4>In a Class Action Lawsuit, Potential Settlements Would Be Distributed Evenly Among All Plaintiffs:</h4> <p>In contrast to an MDL, in a class action lawsuit, a potential settlement would be distributed evenly among all plaintiffs.</p> <p>This would occur regardless of the individual damages each plaintiff has suffered.</p> <p>To conclude, while there is currently no EzriCare Class Action Lawsuit, a multidistrict litigation (MDL) may be established to compensate for injuries and serious infections resulting from EzriCare Artificial Tears and Delsam Pharma Artificial Tears.</p> <p>It’s important to understand the differences between MDL and class action lawsuits, as well as how potential settlements would be distributed in each case.</p>

Chicago

Case Types We Handle

Edwardsville

Case Types We Handle

St. Louis

Case Types We Handle

Illinois

Missouri

Other Dangerous Drugs

Dangerous Drugs

Other Defective Products

Defective Products

Other Exposure Cases

Chemical Exposure

About

TorHoerman Law

Our firm is about people. That is our motto and that will always be our reality.

We do our best to get to know our clients, understand their situations, and get them the compensation they deserve.

At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.

Chicago Office

Edwardsville Office

St. Louis Office

About

Our Team

Without our team, we would’nt be able to provide our clients with anything close to the level of service they receive when they work with us.

The TorHoerman Law Team commits to the sincere belief that those injured by the misconduct of others, especially large corporate profit mongers, deserve justice for their injuries.

Our team is what has made TorHoerman Law a very special place since 2009.

Chicago Office

Edwardsville Office

St. Louis Office

About

Resources

Other Resources

EzriCare Lawsuit [2026 Update] | Artificial Tears Recall

Use the chatbot to find out if you qualify to file an EzriCare Lawsuit claim.

Contact TorHoerman Law for a free consultation.

Last Updated: June 15th, 2026

Key takeaways:

The FDA has recalled Delsam Pharma and EzriCare Artificial Tears, having been linked to 80+ infections nationwide — resulting in at least four (4) deaths and four (4) individuals needing eye removals.
Recall reasons include possible bacterial contamination, drug-resistant Pseudomonas Aeruginosa (CRPA) presence, and an ongoing CDC investigation into the manufacturing process.
Individuals who suffered from vision loss, infections, or other health issues after using these products may be eligible to file an EzriCare Lawsuit Claim.

Most Recent Updates:

The FDA investigation linked EzriCare Artificial Tears to a multistate outbreak of drug-resistant Pseudomonas aeruginosa infections, affecting 81 individuals across 18 states.
Scientists utilized Whole Genome Sequencing (WGS) to trace the infections back to a common source, finding that the bacterial strains in patients were closely related.
The outbreak has led to several lawsuits against EzriCare and Delsam Pharma due to severe health complications, including permanent vision loss, surgical removal of eyeballs, and four deaths, with the CDC advising against the use of the contaminated eye drops.

Intro to the EzriCare Lawsuit

On this page, we’ll discuss an overview of the EzriCare Lawsuit, updates surrounding the EzriCare Artificial Tears Lawsuit, where bacterial contamination cases have been reported so far, who qualifies to file EzriCare lawsuit claims, and much more.

EzriCare Lawsuit Overview & Artificial Tears Recall Information

EzriCare Artificial Tears and Delsam Pharma Artificial Tears have been recalled by the US Food and Drug Administration (FDA) and are under investigation by the Centers for Disease Control and Prevention (CDC).

The US Food and Drug Administration (FDA) has issued a warning, urging consumers not to use EzriCare Artificial Tears and Delsam Pharma Artificial Tears due to a potential bacterial contamination.

The recalled eye drops have been linked to over 80 infections across the country, with at least four people dying and four people needing their eyes removed as a result of bacterial contamination.

If you or a loved one used EzriCare Artificial Tears or Delsam Pharma Artificial Tears and subsequently suffered permanent vision loss, were diagnosed with an infection, or had vision problems, you may be eligible to file an EzriCare Lawsuit Claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to see if you qualify to file a claim instantly.

Our law firm has secured over $4 billion in compensation for people harmed at no fault of their own.

We’re here to help guide you through the legal process and advocate for your best interests.

Reach out to us for more information.

Lawsuit Updates

January 10, 2025

In late December 2024, Alcon Laboratories issued a voluntary recall of one lot of Systane Lubricant Eye Drops Ultra PF due to potential fungal contamination, according to the U.S. Food and Drug Administration (FDA).

The affected product, sold in 25-count boxes nationwide both in stores and online, bears lot number 10101 with an expiration date of September 2025.

The recall follows a consumer complaint reporting foreign material in a sealed vial, later identified as fungal in nature.

While no adverse events have been reported yet, fungal contamination in eye drops can lead to severe eye infections, partial or total blindness, and, in rare cases, life-threatening complications for immunocompromised individuals.

Consumers are advised to:

Stop using the product immediately if it matches the recalled lot.
Return it to the place of purchase for a refund or replacement.
Seek medical attention if experiencing any eye-related issues after using the drops.

This recall comes after similar concerns in the artificial tears market, including contaminated products linked to multiple deaths and vision loss last year.

The FDA continues to monitor and address these safety risks.

If you or a loved one used Artificial Tears, or other recalled products included in the recall, and subsequently experienced vision loss, eye infection, or other injuries, you may be eligible to file an Artificial Tears Lawsuit claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify in under two minutes.

January 10, 2025

September 6, 2024

The EzriCare Artificial Tears lawsuit is ongoing.

The EzriCare Artificial Tears lawsuit revolves around the contamination of eye drops that resulted in severe bacterial infections.

A key factor in this issue is the FDA’s backlog of factory inspections, particularly in high-priority regions like Asia.

Due to the pandemic, FDA inspections dropped by nearly 40%, leaving many plants, including those producing critical medications, without oversight. Concerns about drug shortages have limited the FDA’s ability to act swiftly on violations.

Moreover, the agency’s current inspection approach—primarily focused on physical inspections—has been criticized for not adequately detecting quality issues.

Experts like Dr. Kevin Schulman suggests that U.S. pharmacy chains should purchase from higher-quality manufacturers to mitigate risks like those seen in the EzriCare case.

If you or a loved one used EzriCare Artificial Tears, Delsam Artificial Tears, or other products included in the recall, and subsequently experienced vision loss, eye infection, or other injuries, you may be eligible to file an EzriCare Artificial Tears Lawsuit claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify in under two minutes.

September 6, 2024

April 4, 2024

The Artificial Tears Lawsuit is ongoing and our firm is still accepting new clients.

Several brands of artificial tears and eye drops have been recalled in the past year due to bacterial contamination in manufacturing facilities abroad.

These recalls followed a Food and Drug Administration (FDA) inspection that raised questions about the sterility of these products

EzriCare was the first and most prominent artificial tears brand identified as potentially containing Bacterium Pseudomonas Aeruginosa.

Eye-care products have a higher risk of physical harm because they’re applied directly to the eye, which means they can bypass some of the body’s natural defenses against contaminants.

Manufacturing and storing eyedrops in a sterile way is also difficult.

Contaminated eye products pose serious risks, including infections that could lead to severe, potentially life-threatening conditions.

In February 2023, a recall involving contaminated eye-care products was associated with 14 cases of vision loss and four fatalities, with some patients requiring surgical intervention to remove their eyes

The recalls have largely involved over-the-counter eye drops and ointments, including “copycat” eye drops, which are designed to look like common brands but haven’t been approved by the F.D.A. and sometimes carry misleading health claims

Lawsuits are still being filed against EzriCare and other companies whose products were contaminated with dangerous bacteria.

If you or a loved one have used any recalled brands of artificial tears or eyedrops and are experiencing symptoms, it is essential to collect the following evidence for potential legal claims:

Medical records
The artificial tears you used
Receipts of purchase for recalled products
Any other documentation proving your use of recalled artificial tears and subsequent health problems

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page for an instant case evaluation.

April 4, 2024

March 19, 2024

The Artifical Tears Lawsuit is ongoing and our firm is still accepting new clients.

The FDA has recently alerted consumers about the dangers of unapproved eye drops sold online, including brands like South Moon, Rebright, and FivFivGo, due to the risk of eye infections.

These products, which are marketed for conditions such as glaucoma, are raising concerns about consumer health and safety.

This warning comes amid no reported adverse events from these brands, but there have been reports of potentially counterfeit products causing issues such as eye irritation, pain, and infection.

In a related development, Brassica Pharma has voluntarily recalled four eye ointment products after FDA inspections raised sterility concerns.

The recalled products, including two under Walmart’s Equate brand and others from CVS Health and AACE Pharmaceuticals, highlight an ongoing concern with eye safety.

The recall spans products with expiration dates from February 2024 to September 2025.

This action follows a series of recalls affecting 27 eye drop products from various retailers, sparked by risks of infection leading to vision loss or even blindness.

A February 2023 warning against EzriCare and Delsam Pharma’s Artificial Tears linked these products to an outbreak of drug-resistant bacteria, affecting 81 patients with serious outcomes, including vision loss, surgical eyeball removal, and death.

Consumers are urged to stop using the recalled ointments and any of the implicated eye drops, to dispose of them properly, or to return them where they were purchased.

Contact our Lawyers for a free consultation, or use the chatbot on this page to find out if you qualify to file an Artificial Tears claim instantly.

March 19, 2024

February 13, 2024

On February 5th, the FDA released their findings on their investigation into bacteria contaminated eye drops.

The investigation linked a multistate outbreak of drug-resistant Pseudomonas aeruginosa infections to EzriCare Artificial Tears.

The outbreak, spanning 18 states with 81 confirmed cases, has been traced back to EzriCare Artificial Tears.

Pseudomonas aeruginosa is a type of bacteria commonly found in the environment, and in people with weakened immune systems or with wounds, the bacteria can cause severe infections.

The Pseudomonas aeruginosa germ is known for being resistant to many antibiotics, making said infections difficult to treat.

Whole Genome Sequencing (WGS) was used to trace the outbreak back to the EzriCare Artificial Tears outbreak.

WGS is a process that determines the complete DNA sequence of an organism’s genome at a single time, essentially taking a detailed photo of all the genes in a germ to see its complete DNA “blueprint.”

Scientists use this “photo” to see if germs from different people match up, helping to figure out if there’s a common source for an infection.

In the case of the EzriCare Artificial Tears outbreak, scientists used WGS to analyze the DNA of the Pseudomonas aeruginosa bacteria that was isolated from patients who used the artificial tears.

By comparing these sequences researchers found that the bacterial strains were closely related to each other, indicating a common source of infection.

Several civil lawsuits have been filed against EzriCare and Delsam Pharma, the companies behind the artificial tears, by individuals who faced severe health complications due to the drug-resistant nature of the bacteria.

These health complications include 14 individuals experiencing permanent vision loss, four undergoing surgical removal of an eyeball, and four fatalities.

The CDC advises discontinuing the use of EzriCare Artificial Tears and seeking medical care if symptoms of an eye infection are present.

The FDA recall status for the products remains active, urging consumers not to use these products.

If you or a loved one have suffered infections or injuries after using contaminated EzriCare Eyedrops, you may be eligible to file a lawsuit.

Contact TorHoerman Law or use the chatbot on this page to find out if you qualify for the EzriCare Lawsuit instantly.

February 13, 2024

September 11, 2023

On August 22nd, the FDA released a new warning urging vendors and consumers to stop selling and using two additional types of artificial tear drops.

The two types of eyedrops are Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops, and they are believed to be contaminated with bacteria and or fungi.

In part of its statement, the FDA said it conducted sampling and testing of these products and found that they both are contaminated with microbes and are not sterile.

As of September 9th, the FDA has not received any reports of these additional eye drop types causing injury, however, they continue to warn that the risk of injury from using these products is high.

If you used EzriCare or Delsam eye drops and subsequently suffered from eye pain, injury, or infection you may be eligible to file an EzriCare Eye Drops Lawsuit.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a EzriCare Eye Drops Lawsuit instantly.

September 11, 2023

May 1, 2023

A Summary of What’s Happened So Far

On February 9th, 2023, a Florida woman filed a lawsuit against EzriCare artificial tears, citing a resistant bacterial infection that caused her unrelenting pain after using the eye drops.

This came a week after EzriCare issued a nationwide recall due to possible bacterial contamination of Pseudomonas aeruginosa in their eye drops.

Since that first lawsuit was filed, the CDC has registered 81 cases across 18 states of infections caused by EzriCare eye drops.

Delsam has also issued recalls for contaminated eye drops — Delsam distributes eye drops from the same manufacturer as EzriCare.

Out of these 81 infections, there have been four deaths, four cases of eyeballs being surgically removed, and 14 cases of vision loss.

Symptoms of possible infection typically include, but are not limited to:

Yellow, green or clear discharge from the eye;
Eye or eyelid redness;
The sensation of something being in the eye;
Increased sensitivity to light; or
Blurry vision

In April of this year, an FDA inspection of the facility where the EzriCare and Delsam eye drops are produced concluded that the manufacturing process lacked measures to ensure product sterility, specifically in product batches that were produced between December 2020 and April 2022.

Some of their findings showed that the water filtration system was not fully functioning and that the airflow in the factory’s aseptic cleaning rooms were limited.

Both of these instances can create conditions that allow bacteria to flourish.

This lawsuit is still in early pre-trial stages, and new cases of infection are still being discovered.

If you used EzriCare or Delsam eye drops and subsequently suffered from eye pain, injury, or infection you may be eligible to file an EzriCare Artificial Tears Lawsuit.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a EzriCare Artificial Tears Lawsuit instantly.

May 1, 2023

EzriCare and Delsam Pharma Artificial Tears Lawsuits Filed by Consumers

Contaminated artificial tears manufactured by Global Pharma Healthcare and sold by EzriCare and Delsam Pharma have been linked to at least four deaths, four surgical removal of eyeballs, and at least 14 cases of vision loss.

Lawsuits are being filed by people injured by EzriCare and Delsam Pharma’s Artificial Tears.

EzriCare Lawsuit; EzriCare and Delsam Pharma Lawsuit; EzriCare Artificial Tears Lawsuit; Artificial Tears Lawsuits; EzriCare And Delsam Pharma Artificial Tears Lawsuits Filed By Consumers

If you or a loved one used contaminated EzriCare Eye Drops or Delsam Pharma Artificial Tears and subsequently suffered vision loss or other health problems, you may be eligible to file an EzriCare Lawsuit.

Contact TorHoerman Law for a free case review.

You can also use the chatbot on this page to find out if you qualify for the EzriCare Eye Drops Lawsuit instantly.

These eye drops are an over the counter product and have put consumer health at risk.

Injuries Related to Contaminated EzriCare Eye Drops and Delsam Pharma’s Artificial Tears

Contaminated eye drops sold by EzriCare and Delsam Pharma have been linked to a number of serious injuries and adverse events.

EzriCare Lawsuit; EzriCare and Delsam Pharma Lawsuit; EzriCare Artificial Tears Lawsuit; Artificial Tears Lawsuits; EzriCare And Delsam Pharma Artificial Tears Lawsuits Filed By Consumers; Injuries Related To Contaminated EzriCare Eye Drops And Delsam Pharma’s Artificial Tears

Injuries related to pseudomonas aeruginosa infection from contaminated EzriCare Artificial Tears and Delsam Artificial Tears include:

Permanent vision damage
Severe infection
Vision loss
Other serious injuries and adverse health effects

FDA Warns Consumers to Avoid EzriCare and Delsam Pharma's Artificial Tears

In early 2023, the US Food and Drug Administration (FDA) released a warning to consumers to not use or purchase EzriCare or Delsam Pharma Eye Drops due to potential bacterial contamination.

Global Pharma Healthcare issued a voluntary recall of Artificial Tears Lubricant Eye Drops due to possible contamination on February 2nd, 2023.

According to the warning, the FDA recommended a recall due to Global Pharma’s:

“…current good manufacturing practice (CGMP) violations, including lack of appropriate microbial testing, formulation issues, and lack of proper controls concerning tamper-evident packaging.”

In regard to Global Pharma’s track record, the FDA warning states that the company manufactures and distributes ophthalmic drugs in multi-use bottles, without an adequate preservative.

The dangerous bacteria involved in the Global Pharma/Delsam/EzriCare recall is Verona Integron-mediated Metallo-β-lactamase (VIM)- and Guiana-Extended Spectrum-β-Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA).

Global Pharma Healthcare was also put on an import alert due to the bacterial growth in artificial tears products, preventing further contaminated EzriCare artificial tears and Delsam Pharma artificial tears from entering the United States.

Outbreak Of Bacterial Infections Linked To EzriCare Artificial Tears Eye Drops

National and local health departments are urging consumers to stop using EzriCare Artificial Tears immediately.

Global Pharma Healthcare has issued a voluntary recall on their products and the national media has begun reporting on the dangers of using EzriCare Artificial Tears.

Carbapenem Resistant Pseudomonas Aeruginosa (CRPA) can cause severe infections, and its presence in EzriCare Artificial Tears Eye Drops and Delsam Pharma Artificial Tears Eye Drops is especially concerning.

Pseudomonas Aeruginosa often resist antibiotics.

Pseudomonas Aeruginosa Bacteria, when transmitted through eye drops, can lead to severe eye infections, blood infections, and other serious health problems, potentially leading to death.

Severe bacterial infections have been reported in:

California
Colorado
Connecticut
Florida
New Jersey
New Mexico
New York
Nevada
Texas
Utah
Washington
Wisconsin

CDC Investigates Multistate Outbreak Of Eye Infections

The Centers for Disease Control and Prevention (CDC) warning states that the agency is looking into the source of the contamination and following-up with individuals who’ve been effected.

The CDC is investigating the outbreak of an:

“…extensively drug-resistant strain of Verona Integron-mediated Metallo-β-lactamase (VIM) and Guiana-Extended Spectrum-β-Lactamase (GES)-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) in 12 states.”

The CDC also says that although most patients used several different brands of artificial tears, EzriCare Artificial Tears were commonly mentioned by those suffering from an ocular infection.

The CDC urges patients immediately discontinue the use of EzriCare Artificial Tears eye drops.

About Pseudomonas Aeruginosa Infections

Pseudomonas infections are caused by Pseudomonas Aeruginosa Bacteria.

Typically, these infections can affect a variety of body sites, including the skin, lungs, urinary tract, and bloodstream, and can cause symptoms such as fever, redness, and pus.

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a type of P. aeruginosa that has developed resistance to carbapenems, a class of antibiotics often used to treat severe bacterial infections.

Pseudomonas infections are especially dangerous for people with weakened immune systems.

In some cases, Pseudomonas Aeruginosa infections have resulted in the death of patients.

CRPA Eye Infections: Warning Signs and Symptoms

Eye infection symptoms can range between minor to significant and debilitating.

The symptoms of Carbapenem-resistant Pseudomonas aeruginosa (CRPA) eye infections can include:

Redness
Swelling
Pain or discomfort
Drainage or discharge from the eye
Blurred vision
Increased sensitivity to light
Eyelid swelling or tenderness
Itching or burning sensation
Pink eye
Infected tissue
Fever
Headache

If you have used EzriCare Artificial Tears and are experiencing any of the about symptoms, seek medical attention immediately.

EzriCare Eye Drops Lawsuits: Do You Qualify?

Our attorneys are investigating EzriCare Artificial Tears Lawsuits and are speaking to potential clients about filing claims against Global Pharma Healthcare, Ezricare, Delsam Pharma, and any other responsible parties.

TorHoerman Law works on a contingency fee basis, which means we do not charge for legal representation unless your case wins compensation.

Contact us today to discuss your options and the legal process for EzriCare Infection Lawsuits.

Our product liability team can assist you with some important steps in filing an EzriCare Lawsuit, including gathering evidence, assessing damages, and determining liability.

Gathering Evidence For The Potential EzriCare Eye Drops Lawsuit

Evidence is extremely important in personal injury claims, especially those concerning a defective and contaminated product like EzriCare and Delsam Pharma Eye Drops.

Evidence for an EzriCare Artificial Tears Lawsuit may include:

Medical records
Receipts of purchase for EzriCare Artificial Tears brand eye drops
Proof of eye infection or other bacterial infection
Any other proof linking vision loss or infection to the use of EzriCare drops

Assessing Damages For A Potential EzriCare Lawsuit

Damages are the total amount of losses, economic and non-economic, resulting from your injuries.

Damages in an EzriCare Lawsuit may include:

Medical bills
Lost wages and lost earning ability
Permanent disability
Pain and suffering
Emotional damages
Wrongful death
Other compensatory and punitive damages.

The amount in damages an individual is eligible to claim will be dependent on their evidence and the strength of their individual case.

To learn more about your potential Bacterial Contamination Lawsuit, contact TorHoerman Law.

TorHoerman Law: Investigating EzriCare Lawsuit Claims

TorHoerman Law is currently investigating EzriCare Artificial Tears Lawsuit.

Global Pharma Healthcare’s recalled Ezricare Artificial Tears have been linked to eye infection, bacterial infection, bloodstream infection, and potentially other complications.

EzriCare Lawsuit; EzriCare Lawyers, EzriCare Artificial Tears Attorneys, EzriCare Lawsuit Lawyers

If you or a loved one used EzriCare Artificial Tears, eye drops, or other EzriCare products, and subsequently developed eye infections, bacterial infections, or other complications, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to see if you qualify to file a claim instantly.

Frequently Asked Questions

The main reasons for the EzriCare Eye Drops recall are:
- Possible bacterial contamination of the product.
- The presence of drug-resistant Pseudomonas Aeruginosa (CRPA) in consumers.
- The ongoing investigation by CDC into the manufacturing process.
Possible bacterial contamination of the product

EzriCare Artificial Tears and Delsam Pharma Artificial Tears are recalled due to a risk of bacterial contamination.

This contamination could have potentially originated during the manufacturing or transportation process of these products.

The presence of drug-resistant Pseudomonas Aeruginosa (CRPA) in consumers

Consumers have been found to have bacterial infections caused by Drug-Resistant Pseudomonas Aeruginosa (CRPA).

These infections are directly linked to the use of the recalled eye drop products.

The ongoing investigation by CDC into the manufacturing process

The Centers for Disease Control and Prevention (CDC) is currently investigating both opened and unopened bottles of these eye drops.

The aim of the investigation is to determine whether the contamination occurred during the manufacturing process.

To conclude, EzriCare Eye Drops were recalled due to potential bacterial contamination, infections caused by CRPA in consumers, and the ongoing investigation by the CDC into the product’s manufacturing process.

Learn more
The following eye drops are contaminated and have been recalled:
- EzriCare Artificial Tears Lubricant Eye Drops.
- Delsam Pharma Artificial Tears Lubricant Eye Drops.
- Delsam Pharma’s Artificial Eye Ointment.
- Brimonidine Tartrate Ophthalmic Solution, 0.15%.
- Purely Smoothing 15% MSM Drops.
EzriCare Artificial Tears Lubricant Eye Drops

This is an over-the-counter product used by a large number of consumers.

The product has been linked to eye infections and thus, has been recalled.

Delsam Pharma Artificial Tears Lubricant Eye Drops

Similar to the EzriCare drops, Delsam Pharma’s artificial tears have also been recalled.

This is also an over-the-counter product that is connected to reported eye infections.

Delsam Pharma’s Artificial Eye Ointment

This is another over-the-counter product from Delsam Pharma that has been linked to eye infections and consequently, has been recalled.

Brimonidine Tartrate Ophthalmic Solution, 0.15%

This prescription eye drop is used by patients diagnosed with open-angle glaucoma or ocular hypertension.

Due to the link with eye infections, this product has also been recalled.

Purely Smoothing 15% MSM Drops

This over-the-counter product is the final eye drop on the recall list.

It too has been linked to cases of eye infections.

To conclude, the contaminated and recalled eye drops include products from both EzriCare and Delsam Pharma, including their Artificial Tears, the Artificial Eye Ointment from Delsam Pharma, the Brimonidine Tartrate Ophthalmic Solution, and the Purely Smoothing 15% MSM Drops.

Do I Qualify?
Let’s explore the potential health issues linked to the use of EzriCare contaminated eye drops.

Potential health problems associated with EzriCare contaminated eye drops include:
- Severe eye infections
- Risk of blood infection
- Potential for permanent or partial vision loss
- Urinary tract infections
- Respiratory infections
Severe Eye Infections

Bacterial contamination is a serious concern when it comes to artificial tears eye drops, such as those manufactured by Global Pharma Healthcare.

The type of bacterial contamination present can lead to serious eye infections, necessitating intensive medical treatment.

Risk of Blood Infection

In some severe cases, the bacteria from contaminated eye drops can potentially enter the bloodstream leading to sepsis, a serious and potentially fatal blood infection.

This can occur if the bacteria move from the eye into the bloodstream.

Potential for Permanent or Partial Vision Loss

Infections caused by contaminated eye drops can lead to damage to the eye, which can result in permanent or partial vision loss.

If the infection is not treated promptly and effectively, the risk for significant vision loss increases.

Urinary Tract Infections

Although less common, the bacteria from contaminated eye drops can potentially cause urinary tract infections.

These types of infections can lead to painful urination and may require antibiotic treatment.

Respiratory Infections

Similarly, the bacteria present in the contaminated eye drops can potentially lead to respiratory infections if it finds its way into the respiratory tract.

This could happen if the eye drops are accidentally ingested or enter the respiratory tract.

To conclude, the potential health problems associated with the use of EzriCare contaminated eye drops include severe eye infections, blood infections, permanent or partial vision loss, urinary tract infections, and respiratory infections.

It is critical to avoid using contaminated eye drops to prevent these health complications.

Learn more
The question of whether there is an EzriCare Class Action Lawsuit has been asked frequently.

Key Points:
- There is currently no EzriCare Class Action Lawsuit.
- A multidistrict litigation (MDL) may be established.
- MDL and class action lawsuits are different types of litigations.
- Potential settlements in an EzriCare MDL would be distributed according to individual case facts and damages.
- In a class action lawsuit, potential settlements would be distributed evenly among all plaintiffs.
There is Currently No EzriCare Class Action Lawsuit:

As of now, there is no EzriCare Class Action Lawsuit in place.

This is a point of interest for many individuals who have been affected by EzriCare Artificial Tears and Delsam Pharma Artificial Tears.

A Multidistrict Litigation (MDL) May Be Established:

In response to injuries and serious infections resulting from EzriCare Artificial Tears and Delsam Pharma Artificial Tears, a multidistrict litigation (MDL) may be established.

This is a legal procedure designed to speed up the process of handling complex cases, such as those involving multiple plaintiffs spread across a wide geographic area.

MDL and Class Action Lawsuits Are Different Types of Litigations:

While they may seem similar, MDL and class action lawsuits are different types of litigations.

Understanding this difference is crucial for those involved in such cases.

Potential Settlements in an EzriCare MDL Would Be Distributed According to Individual Case Facts and Damages:

If an EzriCare MDL is established, any potential settlement would be distributed to plaintiffs based on the facts and damages of their individual case.

This means that each plaintiff’s compensation would reflect the specific harm they have suffered.

In a Class Action Lawsuit, Potential Settlements Would Be Distributed Evenly Among All Plaintiffs:

In contrast to an MDL, in a class action lawsuit, a potential settlement would be distributed evenly among all plaintiffs.

This would occur regardless of the individual damages each plaintiff has suffered.

To conclude, while there is currently no EzriCare Class Action Lawsuit, a multidistrict litigation (MDL) may be established to compensate for injuries and serious infections resulting from EzriCare Artificial Tears and Delsam Pharma Artificial Tears.

It’s important to understand the differences between MDL and class action lawsuits, as well as how potential settlements would be distributed in each case.

Do I Qualify?

Published By:

Tor Hoerman

Owner & Attorney - TorHoerman Law

Do You

Have A Case?

Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.

Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Featured Litigations

About TorHoerman Law

At TorHoerman Law, we believe that if we continue to focus on the people that we represent, and continue to be true to the people that we are – justice will always be served.

Do you believe you’re entitled to compensation?

Use our Instant Case Evaluator to find out in as little as 60 seconds!

$495 Million

Baby Formula NEC Lawsuit

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

$20 Million

Toxic Tort Injury

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

$103.8 Million

COX-2 Inhibitors Injury

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

$4 Million

Traumatic Brain Injury

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

$2.8 Million

Defective Heart Device

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.

Guides & Resources

Do You

Have A Case?

Here, at TorHoerman Law, we’re committed to helping victims get the justice they deserve.

Since 2009, we have successfully collected over $4 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Additional EzriCare Lawsuit resources on our website:

You can learn more about the EzriCare Lawsuit by visiting any of our pages listed below:

Illinois

Missouri

EzriCare Lawsuit [2026 Update] | Artificial Tears Recall

Use the chatbot to find out if you qualify to file an EzriCare Lawsuit claim. Contact TorHoerman Law for a free consultation.

Key takeaways:

Most Recent Updates:

Intro to the EzriCare Lawsuit

EzriCare Lawsuit Overview & Artificial Tears Recall Information

Table of Contents

Lawsuit Updates

On February 5th, the FDA released their findings on their investigation into bacteria contaminated eye drops.

A Summary of What’s Happened So Far

EzriCare and Delsam Pharma Artificial Tears Lawsuits Filed by Consumers

Injuries Related to Contaminated EzriCare Eye Drops and Delsam Pharma’s Artificial Tears

FDA Warns Consumers to Avoid EzriCare and Delsam Pharma's Artificial Tears

Outbreak Of Bacterial Infections Linked To EzriCare Artificial Tears Eye Drops

CDC Investigates Multistate Outbreak Of Eye Infections

About Pseudomonas Aeruginosa Infections

CRPA Eye Infections: Warning Signs and Symptoms

EzriCare Eye Drops Lawsuits: Do You Qualify?

Gathering Evidence For The Potential EzriCare Eye Drops Lawsuit

Assessing Damages For A Potential EzriCare Lawsuit

TorHoerman Law: Investigating EzriCare Lawsuit Claims

Frequently Asked Questions

Why Are EzriCare Eye Drops Recalled?

Which Eye Drops are Contaminated?

What Health Problems May Be Associated With EzriCare Contaminated Eye Drops?

Is There an EzriCare Class Action Lawsuit?

Tor Hoerman

Share

Other EzriCare Lawsuit Resources

What Our Clients Have To Say

Edwardsville Office

Chicago Office

St. Louis Office

Naperville Office

Clayton Office

Use the chatbot to find out if you qualify to file an EzriCare Lawsuit claim.

Contact TorHoerman Law for a free consultation.